Noveris Health Sciences Inc. Registered Shares o.N.
Sector and Industry
Technology, Software and Consulting
Performance (1Y)
1,320.00%
Market Cap
-
P/E Ratio
0.13
Dividend Yield
0.00 %
Earnings per Share
1.50 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Alphabet Inc. Class C | 3,229.78 Bil. | 357.19 Bil. | 29.04 | +26.58 % | 0.00 | - |
| Alphabet Inc A | 3,221.55 Bil. | 357.19 Bil. | 28.96 | +26.58 % | 0.00 | - |
| Microsoft Corp. | 3,150.10 Bil. | 259.14 Bil. | 36.46 | +14.94 % | 0.00 | - |
| Meta Platforms Inc. Class A | 1,421.97 Bil. | 178.14 Bil. | 28.10 | -7.04 % | 0.00 | - |
| Tencent Holdings Ltd | 592.30 Bil. | 92.71 Bil. | 22.32 | +11.22 % | 0.00 | - |
| Netflix Inc | 337.07 Bil. | 40.13 Bil. | 37.09 | +20.86 % | 0.00 | - |
| SAP SE | 243.26 Bil. | 36.80 Bil. | 33.92 | +129.23 % | 0.00 | - |
| IBM Corp. | 236.31 Bil. | 59.86 Bil. | 26.53 | +68.51 % | 0.00 | - |
| AppLovin Corp. Class A | 194.10 Bil. | 4.86 Bil. | 67.13 | +108.70 % | 0.00 | - |
| Intuit Inc. | 191.47 Bil. | 17.22 Bil. | 57.43 | +28.91 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 1.42 G | 0 Units |
| PRICE DETERMINATION TIME | 06/12/2026 / 06:32:27 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 1.46 | 1.41 |
| PREV. DAY'S PRICE | 1.46 | (06/11) |
| CHANGE DAY BEFORE | -0.04 | -2.74 % |
| 52 WEEK HIGH / LOW | 1.81 (06/09) | 0.05 (02/13) |
Key Figures (in EUR)
| 2027 | 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | - | - | 1.50 | -1.78 | -23.39 |
| DIVIDENDS PER SHARE | - | - | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | - | - | 0.13 | - | - |
| PRICE - BOOK RATIO | - | - | - | - | - |
| PRICE - SALES RATIO | - | - | - | - | - |
| PRICE - CASH FLOW RATIO | - | - | 40.73 | - | - |
Master Data
| WKN | A42208 |
| ISIN | CA66990B1085 |
| SYMBOL | 0NF1 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | NOVERIS HEALTH SCI. |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Technology, Software and Consulting |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -17.44 % | 47.15 % | 615.37 % | 1,162.22 % | 1,320.00 % | -80.55 % | -99.70 % | 925.27 % |
| HIGH | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 | 10.20 | 986.25 | 1.81 |
| LOW | 1.36 | 0.94 | 0.16 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Dividend
per share
NOVERIS HEALTH SCI. does not deliver dividend information
Company profile
Noveris Health Sciences, Inc. is a biotechnology company, which engages in the development of medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder (PTSD). The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.